Disease mechanisms in rheumatology - Tools and pathways: Multiparameter flow cytometry for discovery of disease mechanisms in rheumatic diseases

Arthritis and Rheumatism

Volumn 65, Issue 5, 2013, Pages 1148-1156

  Soloski, Mark J ^a   Chrest, Francis J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN;

ARTICLE; BONE MARROW; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FATE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; PRIORITY JOURNAL; RHEUMATIC DISEASE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMUS; CELLULAR IMMUNITY; EQUIPMENT; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHYSIOLOGY;

ANTIGENS, CD; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; FLOW CYTOMETRY; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; RHEUMATIC DISEASES; T-LYMPHOCYTES;

MLCS; MLOWN;

EID: 84876573001     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37847     Document Type: Article

References (52)

1. Claman HN, Chaperon EA, Triplett RF,. Immunocompetence of transferred thymus-marrow cell combinations [republished in J Immunol 2004;173:9-13]. J Immunol 1966; 97: 828-32.
2. + cells in the generation of killer activity. J Exp Med 1975; 141: 1390-9.
3. Simpson N, Gatenby PA, Wilson A, Malik S, Fulcher DA, Tangye SG, et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum 2010; 62: 234-44.
4. Maecker HT, McCoy JP, Nussenblatt R,. Standardizing immunophenotyping for the Human Immunology Project [published erratum appears in Nat Rev Immunol 2012;12:471]. Nat Rev Immunol 2012; 12: 191-200.
5. Perfetto SP, Chattopadhyay PK, Roederer M,. Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol 2004; 4: 648-55.
6. McLaughlin BE, Baumgarth N, Bigos M, Roederer M, De Rosa SC, Altman JD, et al. Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: panel design by an empiric approach. Cytometry A 2008; 73: 400-10.
7. Appay V, van Lier RA, Sallusto F, Roederer M,. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008; 73: 975-83.
8. Haynes JL,. Principles of flow cytometry. Cytometry Suppl 1988; 3: 7-17.
9. + T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011; 34: 108-21.
10. Sallusto F, Geginat J, Lanzavecchia A,. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 2004; 22: 745-63.
11. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A,. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 875-83.
12. + T cells during the early stage of pregnancy. Clin Exp Immunol 2001; 123: 105-11.
13. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 2007; 8: 639-46.
14. + T reg cells. J Exp Med 2006; 203: 1701-11.
15. + T cells based on antigen-triggered CD137 expression. J Immunol Methods 2008; 339: 23-37.
16. Alter G, Malenfant JM, Altfeld M,. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294: 15-22.
17. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 2009; 10: 116-25.
18. Kunkel EJ, Boisvert J, Murphy K, Vierra MA, Genovese MC, Wardlaw AJ, et al. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol 2002; 160: 347-55.
19. Campbell DJ, Debes GF, Johnston B, Wilson E, Butcher EC,. Targeting T cell responses by selective chemokine receptor expression. Semin Immunol 2003; 15: 277-86.
20. Ebert LM, Schaerli P, Moser B,. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 2005; 42: 799-809.
21. Wu L, Van Kaer L,. Natural killer T cells and autoimmune disease. Curr Mol Med 2009; 9: 4-14.
22. Shi FD, Zhou Q,. Natural killer cells as indispensable players and therapeutic targets in autoimmunity. Autoimmunity 2011; 44: 3-10.
23. Wither J, Cai YC, Lim S, McKenzie T, Roslin N, Claudio JO, et al. Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity. Arthritis Res Ther 2008; 10: R108.
24. Collins C, Shi C, Russell JQ, Fortner KA, Budd RC,. Activation of γδ T cells by Borrelia burgdorferi is indirect via a TLR- and caspase-dependent pathway. J Immunol 2008; 181: 2392-8.
25. Chattopadhyay PK, Betts MR, Price DA, Gostick E, Horton H, Roederer M, et al. The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J Leukoc Biol 2009; 85: 88-97.
26. Nagler A, Lanier LL, Cwirla S, Phillips JH,. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989; 143: 3183-91.
27. Fuchs A, Colonna M,. The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Semin Cancer Biol 2006; 16: 359-66.
28. Titanji K, Sammicheli S, De Milito A, Mantegani P, Fortis C, Berg L, et al. Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection. Immunology 2008; 123: 164-70.
29. Nakken B, Munthe LA, Konttinen YT, Sandberg AK, Szekanecz Z, Alex P, et al. B-cells and their targeting in rheumatoid arthritis: current concepts and future perspectives. Autoimmun Rev 2011; 11: 28-34.
30. Buch MH, Emery P,. New therapies in the management of rheumatoid arthritis. Curr Opin Rheumatol 2011; 23: 245-51.
31. hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010; 32: 129-40.
32. Aghaeepour N, Chattopadhyay PK, Ganesan A, O'Neill K, Zare H, Jalali A, et al. Early immunologic correlates of HIV protection can be identified from computational analysis of complex multivariate T-cell flow cytometry assays. Bioinformatics 2012; 28: 1009-16.
33. Steinbrich-Zollner M, Grun JR, Kaiser T, Biesen R, Raba K, Wu P, et al. From transcriptome to cytome: integrating cytometric profiling, multivariate cluster, and prediction analyses for a phenotypical classification of inflammatory diseases. Cytometry A 2008; 73: 333-40.
34. Boin F, De Fanis U, Bartlett SJ, Wigley FM, Rosen A, Casolaro V,. T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease. Arthritis Rheum 2008; 58: 1165-74.
35. Mahnke Y, Chattopadhyay P, Roederer M,. Publication of optimized multicolor immunofluorescence panels. Cytometry A 2010; 77: 814-8.
36. Murdoch DM, Staats JS, Weinhold KJ,. OMIP-006: phenotypic subset analysis of human T regulatory cells via polychromatic flow cytometry. Cytometry A 2012; 81: 281-3.
37. Lamoreaux L, Koup RA, Roederer M,. OMIP-009: characterization of antigen-specific human T-cells. Cytometry A 2012; 81: 362-3.
38. Lotze MT, Nepom GT,. A nexus of science and clinical immunology: the Federation of Clinical Immunology Societies and the FOCIS Centers of Excellence. Clin Immunol 2008; 127: 119-20.
39. Baggerly KA, Coombs KR,. Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high throughput biology. Ann Appl Biostat 2009; 3: 1309-34.
40. Peng RD, Dominici F, Zeger SL,. Reproducible epidemiologic research. Am J Epidemiol 2006; 163: 783-9.
41. Hahne F, LeMeur N, Brinkman RR, Ellis B, Haaland P, Sarkar D, et al. flowCore: a Bioconductor package for high throughput flow cytometry. BMC Bioinformatics 2009; 10: 106.
42. Roederer M, Nozzi JL, Nason MC,. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011; 79: 167-74.
43. Walther G, Zimmerman N, Moore W, Parks D, Meehan S, Belitskaya I, et al. Automatic clustering of flow cytometry data with density-based merging. Adv Bioinformatics 2009: 686759.
44. Pyne S, Hu X, Wang K, Rossin E, Lin TI, Maier LM, et al. Automated high-dimensional flow cytometric data analysis. Proc Natl Acad Sci U S A 2009; 106: 8519-24.
45. Qiu P, Simonds EF, Bendall SC, Gibbs KD Jr, Bruggner RV, Linderman MD, et al. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat Biotechnol 2011; 29: 886-91.
46. Bendall SC, Simonds EF, Qiu P, Amir el-EA, Krutzik PO, Finck R, et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011; 332: 687-96.
47. Maecker HT, Trotter J,. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 2006; 69: 1037-42.
48. Bandura DR, Baranov VI, Ornatsky OI, Antonov A, Kinach R, Lou X, et al. Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry. Anal Chem 2009; 81: 6813-22.
49. Maecker HT, Lindstrom TM, Robinson WH, Utz PJ, Hale M, Boyd SD, et al. New tools for classification and monitoring of autoimmune diseases [published erratum appears in Nat Rev Rheumatol 2012;8:562]. Nat Rev Rheumatol 2012; 8: 317-28.
50. Maecker HT, Nolan GP, Fathman CG,. New technologies for autoimmune disease monitoring. Curr Opin Endocrinol Diabetes Obes 2010; 17: 322-8.
51. Wang C, Sanders CM, Yang Q, Schroeder HW Jr, Wang E, Babrzadeh F, et al. High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proc Natl Acad Sci U S A 2010; 107: 1518-23.
52. Arce E, Jackson DG, Gill MA, Bennett LB, Banchereau J, Pascual V,. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J Immunol 2001; 167: 2361-9.